We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Single Chest X-Ray Predicts Mortality Risk

By MedImaging International staff writers
Posted on 08 Aug 2019
A new study suggests that a convolutional neural network (CNN) can stratify all-cause mortality risk based on a single chest radiograph.

Developed at Massachusetts General Hospital (MGH; Boston, USA), Harvard Medical School (HMS; Boston, MA, USA), and other institutions, the CNN algorithm, named CXR-risk, uses data from radiologists' diagnostic findings (such as presence of a lung nodule) on a chest x-ray, and combines it with other risk factors, including age, sex and comorbidities in order to predict long-term mortality, including non-cancer death. A deep learning CXR-risk score (very low, low, moderate, high, and very high) is generated based on CNN analysis of a submitted radiograph.

To develop the CNN, the researchers used 41,856 x-rays from the screening radiography arm of the Prostate, Lung, Colorectal, and Ovarian (PLCO) cancer screening trial, a community cohort of asymptomatic nonsmokers and smokers enrolled at 10 U.S. sites from November 8, 1993, through July 2, 2001. The results of the CNN were tested in a further 10,464 cases from the screening radiography arm of the National Lung Screening Trial (NLST), a community cohort of heavy smokers enrolled at 21 U.S. sites from August 2002 through April 2004.

The results revealed a graded association between CXR-risk score and mortality. The very high-risk group had an all-cause mortality of 53% (PLCO) and 33.9% (NLST), compared with the very low-risk group. The association was robust to adjustment for radiologists’ findings and risk factors. Comparable results were seen for lung cancer death, non-cancer cardiovascular death, and respiratory death. The study was published on July 19, 2019, in JAMA Network Open.

“We get chest x-rays to make a diagnosis like pneumonia, but our study shows that there is also free prognostic information about health and longevity on the images. Based on the chest x-ray image alone, AI identified people at up to a 53% risk of death over 12 years,” said lead author Michael Lu, MD, MPH, of MGH and HMS. “Scores calculated using AI may incentivize high-risk individuals to lower their chance of dying with prevention, regular screening, and lifestyle modification.”

Deep learning is part of a broader family of AI machine learning methods based on learning data representations, as opposed to task specific algorithms. It involves CNN algorithms that use a cascade of many layers of nonlinear processing units for feature extraction, conversion and transformation, with each successive layer using the output from the previous layer as input to form a hierarchical representation.

Related Links:
Massachusetts General Hospital
Harvard Medical School

X-Ray Illuminator
X-Ray Viewbox Illuminators
Breast Localization System
MAMMOREP LOOP
Mobile X-Ray System
K4W
Medical Radiographic X-Ray Machine
TR30N HF

Channels

General/Advanced Imaging

view channel
Image: The study developed a marker based on the analysis of routine CT scans of gastric cancer patients treated at UNICAMP. Higher radiodensity values for adipose tissue are linked to a worse prognosis. In contrast, higher values for muscle are linked to a more favorable outcome (Photo courtesy of FCM-UNICAMP)

CT-Derived Biomarker Predicts Outcomes in Gastric Cancer

Gastric cancer, also known as stomach cancer, is the fifth most common malignancy worldwide and often shows heterogeneous outcomes even within the same stage. Prognostic estimates typically rely on tumor-centric... Read more

Industry News

view channel
Image: MIM KineticID is 510(k)-pending software for dynamic PET imaging and kinetic modeling, enabling time-based radiotracer analysis for clinical and research decisions (Photo courtesy of GE Healthcare)

GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026

Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.